ProCE Banner Activity

The Potential of TTFields Therapy in the Treatment of Advanced NSCLC: Expert Discussion of the Phase III LUNAR Trial

Clinical Thought

Lung cancer expert Ticiana Leal, MD, discusses the potential role of TTFields therapy—a novel wearable device delivering electric fields that disrupt dividing cancer cells and lead to an antitumor immune response—in advanced NSCLC.

Released: July 12, 2023

Share

Faculty

Ticiana Leal

Ticiana Leal, MD

Associate Professor of Medicine
Department of Hematology/Oncology
Director, Thoracic Medical Oncology Program
Winship Cancer Institute
Emory University
Atlanta, Georgia

Provided by

Provided by Clinical Care Options LLC

ProCE Banner

Supporters

Supported by an educational grant from Novocure.

Novocure

Disclosure

Primary Author

Ticiana Leal, MD

Associate Professor of Medicine
Department of Hematology/Oncology
Director, Thoracic Medical Oncology Program
Winship Cancer Institute
Emory University
Atlanta, Georgia

Ticiana Leal, MD: consultant/advisor/speaker: Amgen, AstraZeneca, Catalyst, Daiichi-Sankyo, Eisai, EMD Serono, Janssen, Jazz, Merck, Novocure, Regeneron, Roche, Takeda.